Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1848-1857

  Aranow, Cynthia ^a   Kamen, Diane L ^b   Dall'Era, Maria ^c   Massarotti, Elena M ^d   MacKay, Meggan C ^a   Koumpouras, Fotios ^e   Coca, Andreea ^f   Chatham, W Winn ^g   Clowse, Megan E B ^h   Criscione Schreiber, Lisa G ^h   Callahan, Sherri ⁱ   Goldmuntz, Ellen A ⁱ   Keyes Elstein, Lynette ^j   Oswald, Michaela ^a   Gregersen, Peter K ^a   Diamond, Betty ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e WESTERN PENNSYLVANIA HOSPITAL   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j Rho Federal Systems   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA INTERFERON; COLECALCIFEROL; DOUBLE STRANDED DNA ANTIBODY; INTERFERON; PARATHYROID HORMONE; PLACEBO; 25-HYDROXYVITAMIN D; ANTIGEN; ANTIIDIOTYPIC ANTIBODY; CARRIER PROTEIN; CYTOSKELETON PROTEIN; DNA; IFI44 PROTEIN, HUMAN; IFIT1 PROTEIN, HUMAN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; VITAMIN D;

ADULT; ARTHRALGIA; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; HUMAN; HYPERCALCEMIA; IMMUNE RESPONSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTICENTER STUDY; OPEN STUDY; PILOT STUDY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS; CARRIER PROTEINS; CHOLECALCIFEROL; CYTOSKELETAL PROTEINS; DIETARY SUPPLEMENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MYXOVIRUS RESISTANCE PROTEINS; PROSPECTIVE STUDIES; VITAMIN D;

EID: 84933037300     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39108     Document Type: Article

References (29)

1. Adorini L, Penna G., Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4: 404-12.
2. 3 and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001; 99: 82-93.
3. 3 on human B cell differentiation. J Immunol 2007; 179: 1634-47.
4. Aranow C., Vitamin D and the immune system. J Investig Med 2011; 59: 881-6.
5. Abou-Raya A, Abou-Raya S, Helmii M., The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013; 40: 265-72.
6. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM., Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33.
7. Ojaimi S, Skinner NA, Strauss BJ, Sundararajan V, Woolley I, Visvanathan K., Vitamin D deficiency impacts on expression of Toll-like receptor-2 and cytokine profile: a pilot study. J Transl Med 2013; 11: 176.
8. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, et al., Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443-51.
9. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J., Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 2001; 294: 1540-3.
10. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5.
11. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK., Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005; 52: 1491-503.
12. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, et al., Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3958-67.
13. Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, et al., Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2951-62.
14. Mandal M, Tripathy R, Panda AK, Pattanaik SS, Dakua S, Pradhan AK, et al., Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon α. Arthritis Res Ther 2014; 16: R49.
15. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al., The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5: e9193.
16. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al, for the OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550-8.
17. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, etal. The BILAG inded: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJ Med 1993; 86: 447-58.
18. Isenberg DA, Gordon C, for the British Lsles Lupus Assessment Group. From BILAG to BLIPS - disease activity assessment in lupus past, present and future. Lupus 2009; 9: 651-4
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
20. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
21. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL., Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993; 39: 529-33.
22. t method. Methods 2001; 25: 402-8.
23. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al., A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008; 29: 150-64.
24. Kamen DL, Aranow C., The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 2008; 10: 273-80.
25. Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, et al., Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1569-74.
26. MacDermott EJ, Cherian J, Santiago AG, Taimeh Z, Barillas-Arias L, Crow MK, et al., Type 1 interferon pathway activation predicts flares of disease activity in SLE [abstract]. Arthritis Rheum 2008; 58: 3974-5.
27. Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P, et al., Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009; 18: 980-9.
28. Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, Su J, et al., Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 1440-6.
29. Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al., Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012; 14: R221.